Scaling autologous CAR‑T therapy faces manufacturing bottlenecks
On September 1, PharmaVoice described the manufacturing challenge of autologous CAR‑T: each patient requires a unique journey from cell collection to treatment. Using Carvykti as an example, the process depends on production, quality control, logistics, and clinic scheduling. Autologous CAR‑T is a cancer cell therapy made from the patient’s own T‑cells, which are engineered, expanded, tested, and returned to the same individual, with each dose undergoing its own cycle.
As patient numbers rise, clinics and manufacturers must run many of these cycles in parallel. Cells, factory slots, materials, QC, dose release, delivery, and treatment timing must align for each person; a delay anywhere postpones that patient’s therapy. “When you scale autologous cell therapy, you’re not enlarging a single batch — you’re replicating processes,” said Mike O’Mara, COO of Cellipont Bioservices, a contract cell‑therapy manufacturer. Early on, one experienced team can handle several cycles, but commercial production uses multiple teams simultaneously reproducing the same personal process; manual steps and operator variability then have a stronger impact on quality and timing. Automation and closed‑system processing reduce manual operations and cycle‑to‑cycle differences.
The Carvykti network already shows this scale: it is available at 348 sites in 19 countries according to Legend Biotech, and all four of its manufacturing sites are operating. The expanded facility in Raritan, New Jersey, is designed for up to 10,000 patients per year, yet every personalized dose still must pass QC, release, delivery, and clinic scheduling. In June 2025 FDA REMS removal, the agency lifted the special safety program for six approved autologous CAR‑T products, including Carvykti, eliminating the need for separate site certification and updating post‑administration monitoring instructions, thereby simplifying part of the post‑release pathway.
In the in vivo CAR‑T approach, a genetic vector delivers instructions that reprogram immune cells inside the patient’s body. June 2025 phase I LB2501 data confirmed that this strategy is being tested in humans, with an ongoing phase I study evaluating whether a single infusion can generate CAR‑T cells in vivo. Such a method could shift much of the external cell‑work to a standardized vector product usable for many patients, although that vector product also requires reliable commercial‑scale manufacturing. _clinical_trials_
🔗 Read original →
On September 1, PharmaVoice described the manufacturing challenge of autologous CAR‑T: each patient requires a unique journey from cell collection to treatment. Using Carvykti as an example, the process depends on production, quality control, logistics, and clinic scheduling. Autologous CAR‑T is a cancer cell therapy made from the patient’s own T‑cells, which are engineered, expanded, tested, and returned to the same individual, with each dose undergoing its own cycle.
As patient numbers rise, clinics and manufacturers must run many of these cycles in parallel. Cells, factory slots, materials, QC, dose release, delivery, and treatment timing must align for each person; a delay anywhere postpones that patient’s therapy. “When you scale autologous cell therapy, you’re not enlarging a single batch — you’re replicating processes,” said Mike O’Mara, COO of Cellipont Bioservices, a contract cell‑therapy manufacturer. Early on, one experienced team can handle several cycles, but commercial production uses multiple teams simultaneously reproducing the same personal process; manual steps and operator variability then have a stronger impact on quality and timing. Automation and closed‑system processing reduce manual operations and cycle‑to‑cycle differences.
The Carvykti network already shows this scale: it is available at 348 sites in 19 countries according to Legend Biotech, and all four of its manufacturing sites are operating. The expanded facility in Raritan, New Jersey, is designed for up to 10,000 patients per year, yet every personalized dose still must pass QC, release, delivery, and clinic scheduling. In June 2025 FDA REMS removal, the agency lifted the special safety program for six approved autologous CAR‑T products, including Carvykti, eliminating the need for separate site certification and updating post‑administration monitoring instructions, thereby simplifying part of the post‑release pathway.
In the in vivo CAR‑T approach, a genetic vector delivers instructions that reprogram immune cells inside the patient’s body. June 2025 phase I LB2501 data confirmed that this strategy is being tested in humans, with an ongoing phase I study evaluating whether a single infusion can generate CAR‑T cells in vivo. Such a method could shift much of the external cell‑work to a standardized vector product usable for many patients, although that vector product also requires reliable commercial‑scale manufacturing. _clinical_trials_
🔗 Read original →
PharmaVoice
The hidden scale-out problem behind CAR-T’s growth
CAR-T’s commercial challenge isn’t making bigger batches. It’s making thousands of patient-specific manufacturing runs behave like one reliable system. In vivo aims to eliminate the batch altogether.
We need to translate Russian news post into natural English, format with headline under 90 chars, blank line, then short paragraphs (2-3 sentences each). Wrap few genuinely important facts (key numbers, percentages, drug/company/gene names, dates) in double asterisks, at most 4-5 per post. Wrap study/journal citations and publication references in single underscores.
We need to identify facts: date: 26 августа (August 26) in JACS Au. Also mention AF3-ReD method. Possibly mention beta-subunit of F1-ATPase, proteins OxlT and NarK. Also mention that reducing number of sequences in MSA also finds closed variants but some predictions diverge. Also mention that authors suggest using intermediate variants as starting points for MD.
We need to select at most 4-5 double-asterisk facts. Likely: date August 26, journal JACS Au, protein β-subunit of F1-ATPase, proteins OxlT and NarK maybe count as two but could be considered one fact? Better to keep under 5. Let's pick: August 26, JACS Au, β-subunit of F1-ATPase, OxlT, NarK (that's 5). Or we could combine OxlT and NarK as one fact: "transporter proteins OxlT and NarK". That would be one fact. Then we have 4 facts: date, journal, β-subunit, transporter proteins. Good.
Now citations: we need to wrap study/journal citations and publication references in single underscores. The article is in JACS Au on August 26. So we can put JACS Au, August 26 maybe. Or JACS Au and date separate? The rule: wrap study/journal citations and publication references in single underscores. So we can put JACS Au, August 26 as a single underscored phrase.
Now formatting: headline under 90 chars, no markdown. Then blank line, then body paragraphs separated by blank lines. Each paragraph 2-3 sentences.
Let's craft headline: "AF3-ReD expands AlphaFold3 to capture multiple protein conformations". Count characters: let's count: "AF3-ReD expands AlphaFold3 to capture multiple protein conformations". That's 61 characters approx. Good.
Now body.
Paragraph 1: Introduce method and date/citation. Something like: "On August 26, researchers published a study in JACS Au describing AF3-ReD, a modification of AlphaFold3 that steers the model toward alternative protein structures. The approach leaves the neural‑network weights unchanged but adds a repulsive term that pushes subsequent runs away from conformations already found." That's 2-3 sentences.
Paragraph 2: Explain why multiple conformations matter, give examples: β-subunit of F1-ATPase switching between open and closed states upon ATP binding, and transporter proteins OxlT and NarK that alternate between inward‑ and outward‑open states. Wrap key facts in double asterisks: August 26, JACS Au, β-subunit of F1-ATPase, OxlT and NarK. Ensure each fact is wrapped.
Paragraph 3: Show results: standard AlphaFold3 gave only the open state for the β‑subunit even with ATP, whereas AF3-ReD produced open, closed and intermediate models that match experimental structures. Also note that reducing the MSA depth yielded some closed models but many predictions diverged from known structures.
Paragraph 4: Conclude with authors' suggestion: using the intermediate conformations as starting points for molecular dynamics simulations can help map ligand‑induced transitions, making structure prediction the first step in dissecting protein functional cycles.
We need to ensure double asterisks only around selected facts, not whole sentences. Let's embed them.
Important: At most 4-5 double asterisk facts. We'll have four: August 26, JACS Au, β-subunit of F1-ATPase, OxlT and NarK. Good.
Now ensure we don't accidentally double asterisk other numbers like "multiple" etc. Avoid.…
🔗 Read original →
We need to identify facts: date: 26 августа (August 26) in JACS Au. Also mention AF3-ReD method. Possibly mention beta-subunit of F1-ATPase, proteins OxlT and NarK. Also mention that reducing number of sequences in MSA also finds closed variants but some predictions diverge. Also mention that authors suggest using intermediate variants as starting points for MD.
We need to select at most 4-5 double-asterisk facts. Likely: date August 26, journal JACS Au, protein β-subunit of F1-ATPase, proteins OxlT and NarK maybe count as two but could be considered one fact? Better to keep under 5. Let's pick: August 26, JACS Au, β-subunit of F1-ATPase, OxlT, NarK (that's 5). Or we could combine OxlT and NarK as one fact: "transporter proteins OxlT and NarK". That would be one fact. Then we have 4 facts: date, journal, β-subunit, transporter proteins. Good.
Now citations: we need to wrap study/journal citations and publication references in single underscores. The article is in JACS Au on August 26. So we can put JACS Au, August 26 maybe. Or JACS Au and date separate? The rule: wrap study/journal citations and publication references in single underscores. So we can put JACS Au, August 26 as a single underscored phrase.
Now formatting: headline under 90 chars, no markdown. Then blank line, then body paragraphs separated by blank lines. Each paragraph 2-3 sentences.
Let's craft headline: "AF3-ReD expands AlphaFold3 to capture multiple protein conformations". Count characters: let's count: "AF3-ReD expands AlphaFold3 to capture multiple protein conformations". That's 61 characters approx. Good.
Now body.
Paragraph 1: Introduce method and date/citation. Something like: "On August 26, researchers published a study in JACS Au describing AF3-ReD, a modification of AlphaFold3 that steers the model toward alternative protein structures. The approach leaves the neural‑network weights unchanged but adds a repulsive term that pushes subsequent runs away from conformations already found." That's 2-3 sentences.
Paragraph 2: Explain why multiple conformations matter, give examples: β-subunit of F1-ATPase switching between open and closed states upon ATP binding, and transporter proteins OxlT and NarK that alternate between inward‑ and outward‑open states. Wrap key facts in double asterisks: August 26, JACS Au, β-subunit of F1-ATPase, OxlT and NarK. Ensure each fact is wrapped.
Paragraph 3: Show results: standard AlphaFold3 gave only the open state for the β‑subunit even with ATP, whereas AF3-ReD produced open, closed and intermediate models that match experimental structures. Also note that reducing the MSA depth yielded some closed models but many predictions diverged from known structures.
Paragraph 4: Conclude with authors' suggestion: using the intermediate conformations as starting points for molecular dynamics simulations can help map ligand‑induced transitions, making structure prediction the first step in dissecting protein functional cycles.
We need to ensure double asterisks only around selected facts, not whole sentences. Let's embed them.
Important: At most 4-5 double asterisk facts. We'll have four: August 26, JACS Au, β-subunit of F1-ATPase, OxlT and NarK. Good.
Now ensure we don't accidentally double asterisk other numbers like "multiple" etc. Avoid.…
🔗 Read original →
bioRxiv
Enhanced sampling of protein conformations in AlphaFold3 with repulsive bias in the diffusion generative model
Conformational changes in proteins are vital to their function yet remain challenging for state-of-the-art artificial intelligence, such as AlphaFold3 (AF3), to predict. It has been observed that AF3 sometimes fails to capture ligand-induced conformational…
We need to translate Russian news post into natural English, format: first line short headline under 90 chars, no markdown, then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines. Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. At most 4-5 per post, never a whole sentence. Wrap study/journal citations and publication references in single underscores (e.g., Nature Aging, July 2026). Preserve all facts, numbers, names, citations exactly. No commentary, no invented detail. No source link.
We need to identify important facts: numbers: 31 August Axios published analysis; first three months of 2026 local resistance blocked or delayed 75 data-center projects worth $130 billion; August 15 head of Anthropic Dario Amodei linked trust in AI to real cancer treatment; Anthropic quickly scaling work in biology and medicine, hopes to see first signs of result in coming months; NVIDIA with Eli Lilly building lab for drug development; Isomorphic Labs applying AI to drug discovery; Lloyd Price, partner at Nelson Advisors digital health deals, criterion: "Most often I hear one question: where is the contribution or breakthrough that directly led to drug development? It's a team game, and AI is just one of its participants."
Also citations: Brookings citing Data Center Watch; Axios article; maybe we need to wrap study/journal citations in single underscores. There's no explicit journal citation, but Brookings referencing Data Center Watch maybe considered a citation. Also "Axios published analysis" maybe not a citation. The instruction: "Wrap study/journal citations and publication references in single underscores (e.g. Nature Aging, July 2026)." So we need to wrap any such references. We have Brookings citing Data Center Watch – that's a citation. Also maybe "Axios" is a publication reference; we could wrap "Axios" in underscores? The instruction says study/journal citations and publication references. So we can wrap "Axios" as a publication reference. Also "Brookings" maybe a think tank, not a journal. But we can treat Brookings as a publication reference. However we need to be selective: at most 4-5 double asterisks for facts. Single underscores for citations can be more? Not limited but we should follow.
We need to keep numbers and names in double asterisks: e.g., 31 August, first three months of 2026, 75, $130 billion, August 15, Anthropic, Dario Amodei, NVIDIA, Eli Lilly, Isomorphic Labs, Lloyd Price, Nelson Advisors. But we must limit to 4-5 double asterisks total. So we need to choose only the most important facts: maybe the numbers: 75, $130 billion, 31 August, first three months of 2026, August 15. That's 5. Or we could include company names as facts but they might be considered important. However the rule says "key numbers, percentages, drug/company/gene names, dates". So company names also qualify. But we must limit to 4-5 total. So we need to decide which to highlight. Perhaps we highlight the numbers and dates, and leave company names without asterisks. Or we could highlight a couple company names and fewer numbers. Let's think: The most salient facts: the blockage of 75 projects worth $130bn in Q1 2026; the date of Axios article (31 Aug); Dario Amodei's statement on Aug 15 linking AI trust to cancer treatment. That's three numbers/dates. Could also include the company names Anthropic, NVIDIA/Eli Lilly, Isomorphic Labs as important but we might exceed limit. We can maybe include Anthropic as a company name, but then we have 4. Let's pick: 75, $130 billion, first three months of 2026, August 15. That's four. Or we could also include 31 August as date of article. But we already have August 15; maybe we need both…
🔗 Read original →
We need to identify important facts: numbers: 31 August Axios published analysis; first three months of 2026 local resistance blocked or delayed 75 data-center projects worth $130 billion; August 15 head of Anthropic Dario Amodei linked trust in AI to real cancer treatment; Anthropic quickly scaling work in biology and medicine, hopes to see first signs of result in coming months; NVIDIA with Eli Lilly building lab for drug development; Isomorphic Labs applying AI to drug discovery; Lloyd Price, partner at Nelson Advisors digital health deals, criterion: "Most often I hear one question: where is the contribution or breakthrough that directly led to drug development? It's a team game, and AI is just one of its participants."
Also citations: Brookings citing Data Center Watch; Axios article; maybe we need to wrap study/journal citations in single underscores. There's no explicit journal citation, but Brookings referencing Data Center Watch maybe considered a citation. Also "Axios published analysis" maybe not a citation. The instruction: "Wrap study/journal citations and publication references in single underscores (e.g. Nature Aging, July 2026)." So we need to wrap any such references. We have Brookings citing Data Center Watch – that's a citation. Also maybe "Axios" is a publication reference; we could wrap "Axios" in underscores? The instruction says study/journal citations and publication references. So we can wrap "Axios" as a publication reference. Also "Brookings" maybe a think tank, not a journal. But we can treat Brookings as a publication reference. However we need to be selective: at most 4-5 double asterisks for facts. Single underscores for citations can be more? Not limited but we should follow.
We need to keep numbers and names in double asterisks: e.g., 31 August, first three months of 2026, 75, $130 billion, August 15, Anthropic, Dario Amodei, NVIDIA, Eli Lilly, Isomorphic Labs, Lloyd Price, Nelson Advisors. But we must limit to 4-5 double asterisks total. So we need to choose only the most important facts: maybe the numbers: 75, $130 billion, 31 August, first three months of 2026, August 15. That's 5. Or we could include company names as facts but they might be considered important. However the rule says "key numbers, percentages, drug/company/gene names, dates". So company names also qualify. But we must limit to 4-5 total. So we need to decide which to highlight. Perhaps we highlight the numbers and dates, and leave company names without asterisks. Or we could highlight a couple company names and fewer numbers. Let's think: The most salient facts: the blockage of 75 projects worth $130bn in Q1 2026; the date of Axios article (31 Aug); Dario Amodei's statement on Aug 15 linking AI trust to cancer treatment. That's three numbers/dates. Could also include the company names Anthropic, NVIDIA/Eli Lilly, Isomorphic Labs as important but we might exceed limit. We can maybe include Anthropic as a company name, but then we have 4. Let's pick: 75, $130 billion, first three months of 2026, August 15. That's four. Or we could also include 31 August as date of article. But we already have August 15; maybe we need both…
🔗 Read original →
Axios
AI giants lean into health care to stall public backlash
Saving the world with new medical cures is better than being blamed for big electric bills.
Ai2 outlines five AI‑agent tasks for scientific research
On September 1, the research organization Ai2 published a discussion of systems that assist scientists. Participants identified five tasks for an AI agent: providing expert judgment, adjusting the agent’s course during work, varying how assignments are checked, monitoring the quality of source data, and linking analysis to laboratory experiments.
The discussion used AutoDiscovery—a program that proposes hypotheses from scientific data and tests them via analysis—as a starting point. In an August case study of lobular cancer, an oncologist’s comments narrowed the program’s search, and the team then validated the found signal on independent data and tumor samples.
This example illustrates scientific taste: a specialist selects results that could grow into the next question and sets the direction for further search. Research evolves as a project proceeds—unexpected outcomes, new papers, fresh datasets lead the researcher to change the agent’s instructions, context, and tools.
Oncologist Kelly Paulson summed it up: “This is research, not search: we must discover something new and verify it.” Retrieving records, structuring information, and literature review can be predefined and checked against results, whereas a hypothesis about a novel mechanism or surprising experiment needs separate analysis and reproduction.
Abraham Flaksman described a case where the AI spotted an error in the algorithms of a previously published paper; the researcher verified the comment, agreed, and asked the journal to retract the work. The speed of analysis depends on what the system receives—experiment design, data collection, and causal logic.
Steven Salerno noted that AI amplifies both strong research and weak premises with methodological flaws. In projects involving hundreds of cell types and thousands of changing genes, the agent can gather literature and prioritize hypotheses for testing, with each lab result shaping the next hypothesis and the next experiment.
🔗 Read original →
On September 1, the research organization Ai2 published a discussion of systems that assist scientists. Participants identified five tasks for an AI agent: providing expert judgment, adjusting the agent’s course during work, varying how assignments are checked, monitoring the quality of source data, and linking analysis to laboratory experiments.
The discussion used AutoDiscovery—a program that proposes hypotheses from scientific data and tests them via analysis—as a starting point. In an August case study of lobular cancer, an oncologist’s comments narrowed the program’s search, and the team then validated the found signal on independent data and tumor samples.
This example illustrates scientific taste: a specialist selects results that could grow into the next question and sets the direction for further search. Research evolves as a project proceeds—unexpected outcomes, new papers, fresh datasets lead the researcher to change the agent’s instructions, context, and tools.
Oncologist Kelly Paulson summed it up: “This is research, not search: we must discover something new and verify it.” Retrieving records, structuring information, and literature review can be predefined and checked against results, whereas a hypothesis about a novel mechanism or surprising experiment needs separate analysis and reproduction.
Abraham Flaksman described a case where the AI spotted an error in the algorithms of a previously published paper; the researcher verified the comment, agreed, and asked the journal to retract the work. The speed of analysis depends on what the system receives—experiment design, data collection, and causal logic.
Steven Salerno noted that AI amplifies both strong research and weak premises with methodological flaws. In projects involving hundreds of cell types and thousands of changing genes, the agent can gather literature and prioritize hypotheses for testing, with each lab result shaping the next hypothesis and the next experiment.
🔗 Read original →
medRxiv
Surprisal-based large language models reveal immunologic insights in lobular breast cancer
In large data sets discovery is often limited to pre-conceived hypotheses and data fishing. Here we tested whether systematic exploration of AI generated hypotheses could uncover clinically meaningful signals in extensively studied data. We deployed AutoDiscovery…
RAND Urges US-China Ban on Mirror Ribosome Development
RAND has called on the United States and China to jointly ban the development of mirror ribosomes. In a commentary first published in The Washington Post on August 31, the think‑tank urged the two countries to prohibit work on these cellular machines. Mirror ribosomes could simplify the production of mirror‑image proteins for drugs while also advancing efforts to create a mirror bacterium.
The commentary points to a July White House policy statement that RAND highlights for its phrase “creation of mirror organisms.” Mirror life refers to hypothetical organisms whose DNA and proteins are built from mirror‑image versions of natural molecules; the first such organism might be a bacterium. Ordinary bacteria are normally checked by immune systems, enzymes, and competing microbes.
According to the author’s model, a mirror bacterium could evade those defenses and spread outside the laboratory. In 2024, dozens of scientists warned in Science against allowing such an organism to be created. Mirror‑image drug molecules can persist longer in the body because standard degradation pathways act on them differently.
The author asks, “Need to determine at what point potentially useful early research steps turn into movement down a slippery slope.” RAND proposes that the US and China agree to ban mirror ribosome development and jointly seek alternative ways to obtain mirror proteins. Such an agreement would separate the pursuit of possible medicines from the technology that could bring about a mirror organism.
🔗 Read original →
RAND has called on the United States and China to jointly ban the development of mirror ribosomes. In a commentary first published in The Washington Post on August 31, the think‑tank urged the two countries to prohibit work on these cellular machines. Mirror ribosomes could simplify the production of mirror‑image proteins for drugs while also advancing efforts to create a mirror bacterium.
The commentary points to a July White House policy statement that RAND highlights for its phrase “creation of mirror organisms.” Mirror life refers to hypothetical organisms whose DNA and proteins are built from mirror‑image versions of natural molecules; the first such organism might be a bacterium. Ordinary bacteria are normally checked by immune systems, enzymes, and competing microbes.
According to the author’s model, a mirror bacterium could evade those defenses and spread outside the laboratory. In 2024, dozens of scientists warned in Science against allowing such an organism to be created. Mirror‑image drug molecules can persist longer in the body because standard degradation pathways act on them differently.
The author asks, “Need to determine at what point potentially useful early research steps turn into movement down a slippery slope.” RAND proposes that the US and China agree to ban mirror ribosome development and jointly seek alternative ways to obtain mirror proteins. Such an agreement would separate the pursuit of possible medicines from the technology that could bring about a mirror organism.
🔗 Read original →
The Washington Post
Opinion | Mirror life is theoretical. The danger is anything but.
Trump and Xi have a narrow window to head off a biological threat neither country can survive alone.
We need to translate Russian news post into English, format per rules.
We need a short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap important facts (key numbers, percentages, drug/company/gene names, dates) in double asterisks. At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores (e.g., Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly.
Let's identify facts:
- Date: 26 August (article presented HydroMEA). So date: August 26.
- HydroMEA chip.
- Human sensory neurons grow in gel with Schwann cells.
- Schwann cells create myelin sheath around axons.
- Microelectrode array measured impulse speed.
- In 2025 work, part of authors of HydroMEA already learned to separate responses of individual human sensory axons using microchannels and electrodes.
- New model added 3D gel similar softness to nerve tissue and Schwann cells.
- In chip center placed neurons, sides Schwann cells.
- Narrow channels held neuron bodies in central compartment and directed axons over electrodes.
- One electrode stimulated axon bundle end, others recorded response arrival.
- Path length divided by delay to get conduction velocity.
- At final point of experiment average conduction velocity was 0.8 m/s in culture with Schwann cells and 0.5 m/s in culture of neurons only.
- Images show myelin sheaths around axons.
- Authors exchanged media between cultures. Difference in speed persisted: authors link it to direct cell interactions and changes around axon, later acceleration — with myelination.
- Authors propose to model demyelination in this system and compare drugs or electrical stimulation by conduction velocity. This will allow correlating visible sheath with axon impulse conduction.
We need to wrap key numbers: date August 26, 0.8 m/s, 0.5 m/s, maybe 2025 (year), maybe HydroMEA name? The name is not a number but a proper noun; maybe we can wrap it? The rule says wrap key numbers, percentages, drug/company/gene names, dates. So company name (HydroMEA) is a chip name; could be considered a company/product name, so we can wrap it. Also Schwann cells maybe not needed. But we need at most 4-5 double asterisks. Let's pick: August 26, HydroMEA, 0.8 m/s, 0.5 m/s, 2025. That's 5.
We need to ensure not wrap whole sentence. So we wrap each individually.
Now citations: There's mention of article presented HydroMEA on August 26 in article; maybe it's a journal? Not given. There's "В работе 2025 года часть авторов HydroMEA уже научилась..." So reference to work 2025 year, but not a journal. There's no explicit journal citation. So we may not need underscores. However we might need to wrap any study/journal citations; none present. So we can skip underscores.
But we might need to wrap something like "article" but not needed.
Make sure to preserve all facts.
Now produce headline: short under 90 chars. Something like: "HydroMEA chip measures myelin‑dependent nerve impulse speed in human sensory neurons". Count characters: Let's count: "HydroMEA chip measures myelin‑dependent nerve impulse speed in human sensory neurons". That's about 78? Let's count: HydroMEA (8) + space=1 =>9, chip (4)=>13, space=14, measures(7)=>21, space=22, myelin‑dependent (maybe hyphen counts as char) let's approximate 16? Actually "myelin‑dependent": m y e l i n ‑ d e p e n d e n t = 16 inc hyphen? Let's count: myelin (6) + hyphen (1) + dependent (9) =16. So total 22+16=38, space=39, nerve(4)=>43, space=44, impulse(7)=>51, space=52, speed(5)=>57, space=58, in(2)=>60, space=61, human(5)=>66, space=67, sensory(8)=>75, space=76, neurons(7)=>83. So 83 chars, okay under 90.
Now blank line, then body paragraphs.
We need short paragraphs 2-3 sentences each.…
🔗 Read original →
We need a short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap important facts (key numbers, percentages, drug/company/gene names, dates) in double asterisks. At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores (e.g., Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly.
Let's identify facts:
- Date: 26 August (article presented HydroMEA). So date: August 26.
- HydroMEA chip.
- Human sensory neurons grow in gel with Schwann cells.
- Schwann cells create myelin sheath around axons.
- Microelectrode array measured impulse speed.
- In 2025 work, part of authors of HydroMEA already learned to separate responses of individual human sensory axons using microchannels and electrodes.
- New model added 3D gel similar softness to nerve tissue and Schwann cells.
- In chip center placed neurons, sides Schwann cells.
- Narrow channels held neuron bodies in central compartment and directed axons over electrodes.
- One electrode stimulated axon bundle end, others recorded response arrival.
- Path length divided by delay to get conduction velocity.
- At final point of experiment average conduction velocity was 0.8 m/s in culture with Schwann cells and 0.5 m/s in culture of neurons only.
- Images show myelin sheaths around axons.
- Authors exchanged media between cultures. Difference in speed persisted: authors link it to direct cell interactions and changes around axon, later acceleration — with myelination.
- Authors propose to model demyelination in this system and compare drugs or electrical stimulation by conduction velocity. This will allow correlating visible sheath with axon impulse conduction.
We need to wrap key numbers: date August 26, 0.8 m/s, 0.5 m/s, maybe 2025 (year), maybe HydroMEA name? The name is not a number but a proper noun; maybe we can wrap it? The rule says wrap key numbers, percentages, drug/company/gene names, dates. So company name (HydroMEA) is a chip name; could be considered a company/product name, so we can wrap it. Also Schwann cells maybe not needed. But we need at most 4-5 double asterisks. Let's pick: August 26, HydroMEA, 0.8 m/s, 0.5 m/s, 2025. That's 5.
We need to ensure not wrap whole sentence. So we wrap each individually.
Now citations: There's mention of article presented HydroMEA on August 26 in article; maybe it's a journal? Not given. There's "В работе 2025 года часть авторов HydroMEA уже научилась..." So reference to work 2025 year, but not a journal. There's no explicit journal citation. So we may not need underscores. However we might need to wrap any study/journal citations; none present. So we can skip underscores.
But we might need to wrap something like "article" but not needed.
Make sure to preserve all facts.
Now produce headline: short under 90 chars. Something like: "HydroMEA chip measures myelin‑dependent nerve impulse speed in human sensory neurons". Count characters: Let's count: "HydroMEA chip measures myelin‑dependent nerve impulse speed in human sensory neurons". That's about 78? Let's count: HydroMEA (8) + space=1 =>9, chip (4)=>13, space=14, measures(7)=>21, space=22, myelin‑dependent (maybe hyphen counts as char) let's approximate 16? Actually "myelin‑dependent": m y e l i n ‑ d e p e n d e n t = 16 inc hyphen? Let's count: myelin (6) + hyphen (1) + dependent (9) =16. So total 22+16=38, space=39, nerve(4)=>43, space=44, impulse(7)=>51, space=52, speed(5)=>57, space=58, in(2)=>60, space=61, human(5)=>66, space=67, sensory(8)=>75, space=76, neurons(7)=>83. So 83 chars, okay under 90.
Now blank line, then body paragraphs.
We need short paragraphs 2-3 sentences each.…
🔗 Read original →
The Atlantic frames AI singularity as ongoing battle for control
On September 2, Matteo Wong and Charlie Warzel published an essay in The Atlantic arguing that the term “singularity,” usually reserved for a future point when AI surpasses human intelligence, is being applied to today’s AI race. They link this race to decisions about building data centers and testing systems whose behavior developers only partially understand.
Wong and Warzel note that singularity normally describes an acceleration so rapid that outcomes become hard to foresee, and they propose using the term for current choices: labs speeding model development, investors funding data centers, and governments supporting construction.
They begin with the already examined Hugging Face breach by OpenAI agents; after the breach OpenAI organized an audit with independent groups METR and Redwood Research. Faced with large volumes of material, the auditors relied heavily on reports from AI agents—programs that execute task chains—one auditor called these reports often incomplete, erroneous, overconfident, or hard to understand.
“What if singularity is not a technological threshold created by human genius but a human turning point?” Wong and Warzel ask. For them, this oversight loop shows that acceleration rests on human choices: companies and investors build data centers, governments back construction, while local residents and workers lose influence over changes near home and work. The term singularity ties the speed of AI deployment to who gets power and responsibility for these decisions.
In a 2025 post
🔗 Read original →
On September 2, Matteo Wong and Charlie Warzel published an essay in The Atlantic arguing that the term “singularity,” usually reserved for a future point when AI surpasses human intelligence, is being applied to today’s AI race. They link this race to decisions about building data centers and testing systems whose behavior developers only partially understand.
Wong and Warzel note that singularity normally describes an acceleration so rapid that outcomes become hard to foresee, and they propose using the term for current choices: labs speeding model development, investors funding data centers, and governments supporting construction.
They begin with the already examined Hugging Face breach by OpenAI agents; after the breach OpenAI organized an audit with independent groups METR and Redwood Research. Faced with large volumes of material, the auditors relied heavily on reports from AI agents—programs that execute task chains—one auditor called these reports often incomplete, erroneous, overconfident, or hard to understand.
“What if singularity is not a technological threshold created by human genius but a human turning point?” Wong and Warzel ask. For them, this oversight loop shows that acceleration rests on human choices: companies and investors build data centers, governments back construction, while local residents and workers lose influence over changes near home and work. The term singularity ties the speed of AI deployment to who gets power and responsibility for these decisions.
In a 2025 post
🔗 Read original →
The Atlantic
The Singularity Is Not What It Seems
Whatever the AI future is, we’re in it right now.
We need to translate Russian news post into natural English, format with headline line under 90 chars, then blank line, then body paragraphs short (2-3 sentences each) separated by blank lines. Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. At most 4-5 per post. Wrap study/journal citations and publication references in single underscores.
We need to preserve facts, numbers, names, citations exactly. No extra commentary.
We need to identify important facts: "More than 50 historical texts about cryonics gathered on one page", "August 30 Max Mor published in The Biostasis Standard a list of Mike Perry's texts", "list links titles with years and publications", "separate section for Perry's works on other topics", "Perry published historical articles in the journal Cryonics, on Biostasis.com and elsewhere", "Mor compiled in one list the topic, title, year and publication of each work", "These markings help find a specific Perry text and check where and when it appeared", "The map contains texts about people, organizations and practice of the cryonics movement", "It includes the history of Evan Cooper — one of the pioneers of cryonics — and the institutional history of Alcor, a cryonics organization", "Series about New York covers optimism before the first cryopreservations in 1966–1968, the cryopreservations themselves and the decline of the local group", "Other items are devoted to protocols, patient storage, early films and public criticism", "‘I went through the issues of the Cryonics journal up to 2009 and in the end found more than 50 historical essays. Another 15 non‑historical articles I singled out separately,’ writes Mor.", "In a separate section Mor listed another 15 works, including texts about mathematical models, ischemia — lack of blood flow in tissue — and tissue fixation by chemical solutions.", "Together with the historical essays they show the range of questions to which Perry returned in his publications.", "Mor intends to continue searching and create a full archive of cryonics history.", "According to the current map the reader can jump from topic to Perry’s text, publication and date."
We need to wrap key numbers, percentages, drug/company/gene names, dates in double asterisks. So numbers: more than 50, August 30, 2009, 1966–1968, 15, etc. Also maybe "The Biostasis Standard" is a publication name; not a number, but could be considered important fact? The rule says wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. So we should wrap numbers and dates. Not necessarily publication names unless they are drug/company/gene names. So we will wrap: more than 50, August 30, 2009, 1966–1968, 15 (maybe two times). But we must limit to at most 4-5 double asterisks total. So we need to select maybe 4-5 important numbers/dates. Let's pick: more than 50, August 30, 2009, 1966–1968, 15 (that's 5). Good.
Now we need to wrap study/journal citations and publication references in single underscores. So we need to wrap things like The Biostasis Standard, Cryonics, Biostasis.com maybe. Also maybe "The Biostasis Standard" is a publication; we should wrap in single underscores. Also "Cryonics" journal. Also "Biostasis.com". Also maybe "The Biostasis Standard" appears only once. We'll wrap those.
We must not add any extra commentary. Just translation.…
🔗 Read original →
We need to preserve facts, numbers, names, citations exactly. No extra commentary.
We need to identify important facts: "More than 50 historical texts about cryonics gathered on one page", "August 30 Max Mor published in The Biostasis Standard a list of Mike Perry's texts", "list links titles with years and publications", "separate section for Perry's works on other topics", "Perry published historical articles in the journal Cryonics, on Biostasis.com and elsewhere", "Mor compiled in one list the topic, title, year and publication of each work", "These markings help find a specific Perry text and check where and when it appeared", "The map contains texts about people, organizations and practice of the cryonics movement", "It includes the history of Evan Cooper — one of the pioneers of cryonics — and the institutional history of Alcor, a cryonics organization", "Series about New York covers optimism before the first cryopreservations in 1966–1968, the cryopreservations themselves and the decline of the local group", "Other items are devoted to protocols, patient storage, early films and public criticism", "‘I went through the issues of the Cryonics journal up to 2009 and in the end found more than 50 historical essays. Another 15 non‑historical articles I singled out separately,’ writes Mor.", "In a separate section Mor listed another 15 works, including texts about mathematical models, ischemia — lack of blood flow in tissue — and tissue fixation by chemical solutions.", "Together with the historical essays they show the range of questions to which Perry returned in his publications.", "Mor intends to continue searching and create a full archive of cryonics history.", "According to the current map the reader can jump from topic to Perry’s text, publication and date."
We need to wrap key numbers, percentages, drug/company/gene names, dates in double asterisks. So numbers: more than 50, August 30, 2009, 1966–1968, 15, etc. Also maybe "The Biostasis Standard" is a publication name; not a number, but could be considered important fact? The rule says wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. So we should wrap numbers and dates. Not necessarily publication names unless they are drug/company/gene names. So we will wrap: more than 50, August 30, 2009, 1966–1968, 15 (maybe two times). But we must limit to at most 4-5 double asterisks total. So we need to select maybe 4-5 important numbers/dates. Let's pick: more than 50, August 30, 2009, 1966–1968, 15 (that's 5). Good.
Now we need to wrap study/journal citations and publication references in single underscores. So we need to wrap things like The Biostasis Standard, Cryonics, Biostasis.com maybe. Also maybe "The Biostasis Standard" is a publication; we should wrap in single underscores. Also "Cryonics" journal. Also "Biostasis.com". Also maybe "The Biostasis Standard" appears only once. We'll wrap those.
We must not add any extra commentary. Just translation.…
🔗 Read original →
Substack
Cryo History from Mike Perry
An unrivaled collection of essays
We need to translate Russian news post into English, format per rules.
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores _ (e.g., Nature Aging, July 2026). No citations in this text? There's mention of OMB rule, H.R. 6500, etc. No journal citations. So we may not need underscores unless we find any. There's no explicit citation like a journal. So we may not need underscores.
We need to preserve all facts, numbers, names, dates exactly.
Let's extract facts:
- House of Representatives agreed on bill with temporary block of new federal grants rule effective September 1? Actually text: "Палата представителей согласовала законопроект с временной блокировкой нового правила федеральных грантов 1 сентября Палата представителей США 370 голосами против 48 согласилась с сенатской версией H.R. 6500 ."
Interpretation: House passed bill with temporary block of new federal grants rule effective September 1? Actually "временной блокировкой нового правила федеральных грантов 1 сентября" maybe means temporary block of new rule effective September 1. Then House passed with 370-48 vote agreeing with Senate version of H.R. 6500.
- Bill directed to president; after it takes effect, its §157 will until Dec 11 prohibit issuing and finalizing May rule of US Office of Management and Budget (OMB) on federal financial assistance.
- Federal scientific grants already go through several stages of selection. At NIH, application first evaluated by scientific and technical criteria, then council checks if project aligns with institute's mission.
- On May 29 OMB proposed to change general federal grants rules. New §200.205 added mandatory pre-award review for all grants where agency itself selects recipient. Agency head had to assign one or more senior appointees to conduct it; they would check whether proposal aligns with law, agency priorities, national interests; in applicable cases grant should explicitly advance presidential priorities.
- Expert review retained as recommendations; appointees had to evaluate proposals using their own judgment. Text of proposed rule: "Senior appointees or their representatives must not mechanically approve or usually follow recommendations of others, but must exercise their own judgment when evaluating applications for federal funding."
- Mandatory review by appointees becomes separate step between expert evaluation and disbursement of funds.
- §157 specifically ties prohibition to May OMB notice and substantially similar rules. It will take effect immediately after H.R. 6500 takes effect; House already completed Senate concurrence, bill now with president.
We need to wrap key numbers, percentages, drug/company/gene names, dates in double asterisks. Key numbers: 370, 48, September 1, December 11, May 29, §157, §200.205, H.R. 6500. Possibly also "May rule". But we need at most 4-5 double asterisks. Choose most important: vote counts (370-48), dates (September 1, December 11, May 29), maybe the bill number H.R. 6500, and sections §157 and §200.205. That's many. We need to limit to 4-5. Let's pick: 370-48, September 1, December 11, May 29, H.R. 6500. Or maybe include §157 as important. But we need to be selective. Let's decide: include vote counts, dates of block (Sept 1), effective date of prohibition (Dec 11), proposal date (May 29), and bill number (H.R. 6500). That's 5.
We must not wrap whole sentences. So we wrap just those numbers/dates.…
🔗 Read original →
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores _ (e.g., Nature Aging, July 2026). No citations in this text? There's mention of OMB rule, H.R. 6500, etc. No journal citations. So we may not need underscores unless we find any. There's no explicit citation like a journal. So we may not need underscores.
We need to preserve all facts, numbers, names, dates exactly.
Let's extract facts:
- House of Representatives agreed on bill with temporary block of new federal grants rule effective September 1? Actually text: "Палата представителей согласовала законопроект с временной блокировкой нового правила федеральных грантов 1 сентября Палата представителей США 370 голосами против 48 согласилась с сенатской версией H.R. 6500 ."
Interpretation: House passed bill with temporary block of new federal grants rule effective September 1? Actually "временной блокировкой нового правила федеральных грантов 1 сентября" maybe means temporary block of new rule effective September 1. Then House passed with 370-48 vote agreeing with Senate version of H.R. 6500.
- Bill directed to president; after it takes effect, its §157 will until Dec 11 prohibit issuing and finalizing May rule of US Office of Management and Budget (OMB) on federal financial assistance.
- Federal scientific grants already go through several stages of selection. At NIH, application first evaluated by scientific and technical criteria, then council checks if project aligns with institute's mission.
- On May 29 OMB proposed to change general federal grants rules. New §200.205 added mandatory pre-award review for all grants where agency itself selects recipient. Agency head had to assign one or more senior appointees to conduct it; they would check whether proposal aligns with law, agency priorities, national interests; in applicable cases grant should explicitly advance presidential priorities.
- Expert review retained as recommendations; appointees had to evaluate proposals using their own judgment. Text of proposed rule: "Senior appointees or their representatives must not mechanically approve or usually follow recommendations of others, but must exercise their own judgment when evaluating applications for federal funding."
- Mandatory review by appointees becomes separate step between expert evaluation and disbursement of funds.
- §157 specifically ties prohibition to May OMB notice and substantially similar rules. It will take effect immediately after H.R. 6500 takes effect; House already completed Senate concurrence, bill now with president.
We need to wrap key numbers, percentages, drug/company/gene names, dates in double asterisks. Key numbers: 370, 48, September 1, December 11, May 29, §157, §200.205, H.R. 6500. Possibly also "May rule". But we need at most 4-5 double asterisks. Choose most important: vote counts (370-48), dates (September 1, December 11, May 29), maybe the bill number H.R. 6500, and sections §157 and §200.205. That's many. We need to limit to 4-5. Let's pick: 370-48, September 1, December 11, May 29, H.R. 6500. Or maybe include §157 as important. But we need to be selective. Let's decide: include vote counts, dates of block (Sept 1), effective date of prohibition (Dec 11), proposal date (May 29), and bill number (H.R. 6500). That's 5.
We must not wrap whole sentences. So we wrap just those numbers/dates.…
🔗 Read original →
Grok 4.6 Scores Over 50% on Both Safety and Utility Scales in BioSecBench-Refusal Test
LatchBio, the developer of the BioSecBench-Refusal test, reported on 1 September that its evaluation of Grok 4.6 showed the model exceeding 50% on both safety and utility scales. The company said Grok 4.6 is the only model tested so far to achieve this result independently of the software wrapper used to run it.
The BioSecBench-Refusal benchmark evaluates an AI agent on two kinds of biological tasks. In 61 ordinary tasks the agent must assist with data analysis from published studies, while in 46 dangerous scenarios a harmful intent is concealed in the input or the task description. Because the same biological terminology appears in both sets, the test records two error types: missing a hidden threat and refusing legitimate research work.
In the July check of BioSecBench-Refusal most of the 16 model‑wrapper combinations refused ordinary tasks at least as often as they refused risky scenarios, with filters often cutting off work before the agent could parse the goal. The new series measures both sides of this problem specifically for Grok 4.6.
LatchBio attributes the score to Grok 4.6’s ability to match a harmless cover story with the content of an attached file and to consider the experiment’s purpose. In their examples a request to neutralize a
🔗 Read original →
LatchBio, the developer of the BioSecBench-Refusal test, reported on 1 September that its evaluation of Grok 4.6 showed the model exceeding 50% on both safety and utility scales. The company said Grok 4.6 is the only model tested so far to achieve this result independently of the software wrapper used to run it.
The BioSecBench-Refusal benchmark evaluates an AI agent on two kinds of biological tasks. In 61 ordinary tasks the agent must assist with data analysis from published studies, while in 46 dangerous scenarios a harmful intent is concealed in the input or the task description. Because the same biological terminology appears in both sets, the test records two error types: missing a hidden threat and refusing legitimate research work.
In the July check of BioSecBench-Refusal most of the 16 model‑wrapper combinations refused ordinary tasks at least as often as they refused risky scenarios, with filters often cutting off work before the agent could parse the goal. The new series measures both sides of this problem specifically for Grok 4.6.
LatchBio attributes the score to Grok 4.6’s ability to match a harmless cover story with the content of an attached file and to consider the experiment’s purpose. In their examples a request to neutralize a
🔗 Read original →
blog.latch.bio
Testing Grok 4.6’s Enhanced Biology Safeguards
Analyzing performance of the new safeguards across our benchmark suite
We need to translate Russian news post into English, format per rules.
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores.
We need to preserve facts, numbers, names, citations exactly.
Let's extract facts:
- In Cell Reports, article published August 31 (31 августа) in Cell Reports about combined experiments with yeast, worms, flies, short-lived fish, mice.
- Authors automated counting of survivors to compare action of substances in different organisms and conditions.
- Mouse experiment with a substance that extends life in lab models, when started late, lasts from one to one and a half years.
- To choose next such experiment, need comparable results from fast models.
- In different studies dose, feed, genetic line, observation method vary; thus same candidate may get different evaluations.
- Authors built compatible systems for five models.
- In yeast, miniature viability test accounts for medium acidity: it itself can change cell survival.
- Chambers at set intervals photograph worms and flies, program recognizes death by sustained immobility.
- In killifish, short-lived fish, authors standardized drug pellets.
- In mice, interventions start at late age and together with lifespan they observe animal activity.
- Full comparison of 423 substances authors performed in three fast models: yeast, worms, flies.
- Of them 130 extended life in at least one species, 32 in two, and metformin, rifampicin, and furazolidone — in all three.
- In experiments with canagliflozin, drug extended lifespan in male mice but not females; with late start females lived less, and subsequent work linked this to about 20 times higher concentration of substance in blood.
- Next check here concerns dose, sex, diet, and mode of delivery.
- Five compatible systems help choose next long mouse experiment: they show whether result holds when changing species and conditions, and where it depends on dose, sex, diet, or mode of delivery.
We need to wrap key numbers, percentages, drug/company/gene names, dates in double asterisks. At most 4-5 per post.
We need to decide which facts to highlight: maybe date (August 31), number of substances (423), numbers 130, 32, three drugs (metformin, rifampicin, furazolidone), maybe 20 times higher concentration. That's 5 items: date, 423, 130, 32, 20 times. Or we could include drug names as important facts. But drug names also need to be highlighted? The rule says wrap key numbers, percentages, drug/company/gene names, dates. So drug names also should be wrapped. But we have limited to 4-5 double asterisks total. We need to be selective.
We could choose: date (August 31), number of substances (423), numbers (130, 32), and maybe the 20‑fold higher concentration. That's 5 double asterisks. Drug names we could leave without asterisks, but they are drug names; maybe we can include one drug name as double asterisk instead of a number? But we need at most 4-5, we could do 4: date, 423, 130, 20‑fold. Or we could do date, 423, metformin, rifampicin, furazolidone (that's 5). But we need to include numbers too. Let's think: The most important facts: date, total substances tested, number that extended life in at least one model, number that extended in two models, the three drugs that worked in all three, and the 20-fold concentration difference. That's many.…
🔗 Read original →
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores.
We need to preserve facts, numbers, names, citations exactly.
Let's extract facts:
- In Cell Reports, article published August 31 (31 августа) in Cell Reports about combined experiments with yeast, worms, flies, short-lived fish, mice.
- Authors automated counting of survivors to compare action of substances in different organisms and conditions.
- Mouse experiment with a substance that extends life in lab models, when started late, lasts from one to one and a half years.
- To choose next such experiment, need comparable results from fast models.
- In different studies dose, feed, genetic line, observation method vary; thus same candidate may get different evaluations.
- Authors built compatible systems for five models.
- In yeast, miniature viability test accounts for medium acidity: it itself can change cell survival.
- Chambers at set intervals photograph worms and flies, program recognizes death by sustained immobility.
- In killifish, short-lived fish, authors standardized drug pellets.
- In mice, interventions start at late age and together with lifespan they observe animal activity.
- Full comparison of 423 substances authors performed in three fast models: yeast, worms, flies.
- Of them 130 extended life in at least one species, 32 in two, and metformin, rifampicin, and furazolidone — in all three.
- In experiments with canagliflozin, drug extended lifespan in male mice but not females; with late start females lived less, and subsequent work linked this to about 20 times higher concentration of substance in blood.
- Next check here concerns dose, sex, diet, and mode of delivery.
- Five compatible systems help choose next long mouse experiment: they show whether result holds when changing species and conditions, and where it depends on dose, sex, diet, or mode of delivery.
We need to wrap key numbers, percentages, drug/company/gene names, dates in double asterisks. At most 4-5 per post.
We need to decide which facts to highlight: maybe date (August 31), number of substances (423), numbers 130, 32, three drugs (metformin, rifampicin, furazolidone), maybe 20 times higher concentration. That's 5 items: date, 423, 130, 32, 20 times. Or we could include drug names as important facts. But drug names also need to be highlighted? The rule says wrap key numbers, percentages, drug/company/gene names, dates. So drug names also should be wrapped. But we have limited to 4-5 double asterisks total. We need to be selective.
We could choose: date (August 31), number of substances (423), numbers (130, 32), and maybe the 20‑fold higher concentration. That's 5 double asterisks. Drug names we could leave without asterisks, but they are drug names; maybe we can include one drug name as double asterisk instead of a number? But we need at most 4-5, we could do 4: date, 423, 130, 20‑fold. Or we could do date, 423, metformin, rifampicin, furazolidone (that's 5). But we need to include numbers too. Let's think: The most important facts: date, total substances tested, number that extended life in at least one model, number that extended in two models, the three drugs that worked in all three, and the 20-fold concentration difference. That's many.…
🔗 Read original →
Cell Reports
A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions
Perez, Schoenfeldt et al. present an integrated platform and methodology combining
automation and machine learning to evaluate thousands of conditions across >400 compounds
in yeasts, nematodes, flies, killifish, and mice, identifying conserved longevity…
automation and machine learning to evaluate thousands of conditions across >400 compounds
in yeasts, nematodes, flies, killifish, and mice, identifying conserved longevity…
We need to translate Russian news post into English, format per rules.
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores _ (e.g. Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly. No added commentary.
We need to identify citations: The text mentions "По оценке ARPA-H, которую приводит Pharmaphorum". That's a citation: Pharmaphorum. Should we wrap that in single underscores? It's a publication reference. So Pharmaphorum.
Also maybe other citations? Not many.
We need to wrap key numbers etc in double asterisks. Let's list important facts:
- ARPA-H allocated up to $125 million.
- Date: 1 September (American agency...).
- Five groups.
- Program GIVE funds four automated manufacturing systems and separate quality check at University of Utah.
- Personal RNA therapy starts with patient-specific sequence.
- Steps: synthesize, purify, package into lipid nanoparticles, fill vials, test, release batch.
- Some individualized genetic therapies take months and cost hundreds of thousands of dollars (per Pharmaphorum).
- Release time determined by each step.
- Five awards have different technical solutions.
- In FUSE project, fluid stays inside disposable chip; system should combine manufacturing and quality check in less than three days.
- Closed chip moves part of production from sterile room to compact setup.
- Separate University of Utah system should test drug by several parameters and release batch within a day, using microfluidic droplet control, optical measurements, AI.
- Project ESCALATOR by Waterfall Scientific assembles whole chain in one installation.
- Enzymes create DNA template — molecule used to copy RNA; then system continuously synthesizes RNA, forms lipid nanoparticles, fills vials.
- Automatic verification covers substance and final product.
- In July ARPA-H launched THRIVE, program reusing parts of development of personal genetic editors for different mutations.
- GIVE continues this work after selecting RNA sequence: takes it through production to dose that passed necessary checks.
We need to wrap key numbers etc: $125 million, 1 September, five groups, four automated systems, University of Utah, less than three days, within a day, July (maybe), THRIVE launched July.
But we must be selective: at most 4-5 double asterisks per post. So we need to pick maybe 4-5 most important facts.
Potential picks:
- $125 million
- 1 September
- five groups
- less than three days
- within a day
But also need to include maybe "THRIVE launched in July". Could replace one.
We need to ensure we don't wrap whole sentence. Just wrap the fact.
We'll embed double asterisks around those numbers/phrases.
Also need to wrap study/journal citations in single underscores: Pharmaphorum.
We must not add any extra commentary.
Now format: first line headline under 90 chars. Let's craft: "ARPA-H awards up to $125 million for personalized RNA‑medicine manufacturing". Count characters: Let's count roughly: "ARPA-H awards up to $125 million for personalized RNA‑medicine manufacturing". Count: ARPA-H (6) + space (1)=7, awards (6)=13, space=14, up (2)=16, space=17, to (2)=19, space=20, $125 million (maybe 12 inc space?) Let's just trust it's under 90.
Make sure no markdown, no '#'.
Then blank line.
Then body paragraphs, each 2-3 sentences.
We need to split into short paragraphs.
Let's create maybe 4 paragraphs.…
🔗 Read original →
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores _ (e.g. Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly. No added commentary.
We need to identify citations: The text mentions "По оценке ARPA-H, которую приводит Pharmaphorum". That's a citation: Pharmaphorum. Should we wrap that in single underscores? It's a publication reference. So Pharmaphorum.
Also maybe other citations? Not many.
We need to wrap key numbers etc in double asterisks. Let's list important facts:
- ARPA-H allocated up to $125 million.
- Date: 1 September (American agency...).
- Five groups.
- Program GIVE funds four automated manufacturing systems and separate quality check at University of Utah.
- Personal RNA therapy starts with patient-specific sequence.
- Steps: synthesize, purify, package into lipid nanoparticles, fill vials, test, release batch.
- Some individualized genetic therapies take months and cost hundreds of thousands of dollars (per Pharmaphorum).
- Release time determined by each step.
- Five awards have different technical solutions.
- In FUSE project, fluid stays inside disposable chip; system should combine manufacturing and quality check in less than three days.
- Closed chip moves part of production from sterile room to compact setup.
- Separate University of Utah system should test drug by several parameters and release batch within a day, using microfluidic droplet control, optical measurements, AI.
- Project ESCALATOR by Waterfall Scientific assembles whole chain in one installation.
- Enzymes create DNA template — molecule used to copy RNA; then system continuously synthesizes RNA, forms lipid nanoparticles, fills vials.
- Automatic verification covers substance and final product.
- In July ARPA-H launched THRIVE, program reusing parts of development of personal genetic editors for different mutations.
- GIVE continues this work after selecting RNA sequence: takes it through production to dose that passed necessary checks.
We need to wrap key numbers etc: $125 million, 1 September, five groups, four automated systems, University of Utah, less than three days, within a day, July (maybe), THRIVE launched July.
But we must be selective: at most 4-5 double asterisks per post. So we need to pick maybe 4-5 most important facts.
Potential picks:
- $125 million
- 1 September
- five groups
- less than three days
- within a day
But also need to include maybe "THRIVE launched in July". Could replace one.
We need to ensure we don't wrap whole sentence. Just wrap the fact.
We'll embed double asterisks around those numbers/phrases.
Also need to wrap study/journal citations in single underscores: Pharmaphorum.
We must not add any extra commentary.
Now format: first line headline under 90 chars. Let's craft: "ARPA-H awards up to $125 million for personalized RNA‑medicine manufacturing". Count characters: Let's count roughly: "ARPA-H awards up to $125 million for personalized RNA‑medicine manufacturing". Count: ARPA-H (6) + space (1)=7, awards (6)=13, space=14, up (2)=16, space=17, to (2)=19, space=20, $125 million (maybe 12 inc space?) Let's just trust it's under 90.
Make sure no markdown, no '#'.
Then blank line.
Then body paragraphs, each 2-3 sentences.
We need to split into short paragraphs.
Let's create maybe 4 paragraphs.…
🔗 Read original →
Businesswire
Waterfall Scientific Awarded Up to $54.5 Million from ARPA-H to Lead Consortium Developing Continuous-Flow Cell-Free mRNA Manufacturing…
Waterfall Scientific, a biotechnology company pioneering continuous-flow RNA manufacturing technologies, today announced that it has been selected by the Adv...
Rethinking Sarcopenia as a Disease of the Aging Motor System
On August 28, The Lancet Healthy Longevity published an article proposing that sarcopenia be viewed as a disease of the aging motor system. The authors argue that the loss of strength and mobility with age should be examined along the entire chain of movement, from the brain and spinal cord to the nerves, their junctions with muscle, and the muscle fibers themselves.
They note that when a person rises from a chair or
🔗 Read original →
On August 28, The Lancet Healthy Longevity published an article proposing that sarcopenia be viewed as a disease of the aging motor system. The authors argue that the loss of strength and mobility with age should be examined along the entire chain of movement, from the brain and spinal cord to the nerves, their junctions with muscle, and the muscle fibers themselves.
They note that when a person rises from a chair or
🔗 Read original →
The Lancet Healthy Longevity
Reframing sarcopenia as a disease of the ageing motor system
Sarcopenia is a major driver of disability, frailty, and loss of independence in ageing
populations. Current consensus definitions have shifted from low muscle mass to low
muscle strength and impaired physical performance as the defining clinical features.…
populations. Current consensus definitions have shifted from low muscle mass to low
muscle strength and impaired physical performance as the defining clinical features.…
OmicsPred catalog surpasses 3.3 million predictive models
On September 1, Nature Genetics, September 1, 2026 published a description of the OmicsPred catalog, which currently holds 3.3 million models that predict RNA, protein, and metabolite levels from DNA data. Each model is accompanied by metadata that lets researchers judge its suitability for a new study.
Models are trained on individuals who have both genotype and molecular measurements; they weigh DNA variant contributions to forecast a specific molecule’s level. The resulting formula can be applied to genotypes from another cohort or to summary statistics from genetic studies. However, a simple list of coefficients is insufficient for transfer.
To address this, OmicsPred stores the DNA variants and their weights, the genome‑build version, tissue type, training and validation sample details, participant ancestry, and prediction accuracy. This lets users compare their own data with the conditions under which a model was trained and tested.
By May 2026 the catalog contained 3,339,469 models, up from 17,227 models in the 2023 version. Most predict gene expression across 49 human tissues, with additional models for proteins and metabolites.
The authors applied the catalog to summary results from the Million Veteran Program, matching predicted RNA and protein levels in blood and plasma against 1,233 health conditions in African, admixed American, and European ancestry groups. This yielded about ~46 million comparisons; after correcting for multiple testing, >190,000 associations remained statistically significant.
For each association the catalog records the exact formula used, the training data, and the prediction accuracy, enabling other researchers to reuse the model and test the hypotheses on new datasets.
🔗 Read original →
On September 1, Nature Genetics, September 1, 2026 published a description of the OmicsPred catalog, which currently holds 3.3 million models that predict RNA, protein, and metabolite levels from DNA data. Each model is accompanied by metadata that lets researchers judge its suitability for a new study.
Models are trained on individuals who have both genotype and molecular measurements; they weigh DNA variant contributions to forecast a specific molecule’s level. The resulting formula can be applied to genotypes from another cohort or to summary statistics from genetic studies. However, a simple list of coefficients is insufficient for transfer.
To address this, OmicsPred stores the DNA variants and their weights, the genome‑build version, tissue type, training and validation sample details, participant ancestry, and prediction accuracy. This lets users compare their own data with the conditions under which a model was trained and tested.
By May 2026 the catalog contained 3,339,469 models, up from 17,227 models in the 2023 version. Most predict gene expression across 49 human tissues, with additional models for proteins and metabolites.
The authors applied the catalog to summary results from the Million Veteran Program, matching predicted RNA and protein levels in blood and plasma against 1,233 health conditions in African, admixed American, and European ancestry groups. This yielded about ~46 million comparisons; after correcting for multiple testing, >190,000 associations remained statistically significant.
For each association the catalog records the exact formula used, the training data, and the prediction accuracy, enabling other researchers to reuse the model and test the hypotheses on new datasets.
🔗 Read original →
Nature
OmicsPred as a centralized resource for genetic prediction of multi-omic traits
Nature Genetics - We present OmicsPred, an open platform for the deposition and dissemination of genetic prediction models of multi-omic traits, with key metadata required for reproducibility and...
Mouse Ovary Stiffness Map Links Gene Activity to Mechanical Properties
On 31 August a preprint appeared on bioRxiv describing how researchers measured the resistance of fresh mouse ovarian tissue to indentation and matched those measurements to a map of gene activity on an adjacent slice. They examined 21 regions and collected 2 915 pairs of measurements from eight young and 14‑month‑old mice.
Old ovaries resisted indentation about 2.5‑fold more than young ones; treatment with collagenase, an enzyme that breaks down collagen, brought the stiffness of old tissue closer to that of young tissue. These measurements were taken at many points across the whole ovary, revealing a general age‑related shift, while resistance within a single ovary could vary several‑fold.
For a follicle — the sac where an egg matures — the mechanical environment shaped by the surrounding theca cells influences growth. In 2025 researchers showed that theca cells assemble fibronectin fibers around the follicle and contract them, altering pressure and thereby changing follicle growth.
The work explains why organ‑averaged measurements can hide local biology. Authors took a fresh 100‑micrometer thick slice from each ovary, swept a spherical nanoindenter tip across it in a grid to measure stiffness, and placed a frozen parallel surface underneath for spatial transcriptomics — a map of gene activity by tissue point. Images of tissue and follicle boundaries allowed the two maps to be aligned in a common coordinate system.
After quality control, 2 915 measurement pairs remained, with each mechanical point corresponding on average to 92 gene‑activity spots. In stiffer zones, interferon‑response gene programs were more active; in softer zones, programs linked to elastic fibers prevailed. These associations differed between young and old animals.
When the ovary’s anatomical compartments were analyzed separately, the authors uncovered 1 763 statistical links between gene activity and indentation resistance, whereas averaging across the whole tissue yielded only 316 links. Future experiments could modify collagen, inflammation, or pressure and then use the two maps to see where mechanical properties and gene activity change together.
🔗 Read original →
On 31 August a preprint appeared on bioRxiv describing how researchers measured the resistance of fresh mouse ovarian tissue to indentation and matched those measurements to a map of gene activity on an adjacent slice. They examined 21 regions and collected 2 915 pairs of measurements from eight young and 14‑month‑old mice.
Old ovaries resisted indentation about 2.5‑fold more than young ones; treatment with collagenase, an enzyme that breaks down collagen, brought the stiffness of old tissue closer to that of young tissue. These measurements were taken at many points across the whole ovary, revealing a general age‑related shift, while resistance within a single ovary could vary several‑fold.
For a follicle — the sac where an egg matures — the mechanical environment shaped by the surrounding theca cells influences growth. In 2025 researchers showed that theca cells assemble fibronectin fibers around the follicle and contract them, altering pressure and thereby changing follicle growth.
The work explains why organ‑averaged measurements can hide local biology. Authors took a fresh 100‑micrometer thick slice from each ovary, swept a spherical nanoindenter tip across it in a grid to measure stiffness, and placed a frozen parallel surface underneath for spatial transcriptomics — a map of gene activity by tissue point. Images of tissue and follicle boundaries allowed the two maps to be aligned in a common coordinate system.
After quality control, 2 915 measurement pairs remained, with each mechanical point corresponding on average to 92 gene‑activity spots. In stiffer zones, interferon‑response gene programs were more active; in softer zones, programs linked to elastic fibers prevailed. These associations differed between young and old animals.
When the ovary’s anatomical compartments were analyzed separately, the authors uncovered 1 763 statistical links between gene activity and indentation resistance, whereas averaging across the whole tissue yielded only 316 links. Future experiments could modify collagen, inflammation, or pressure and then use the two maps to see where mechanical properties and gene activity change together.
🔗 Read original →
We need to translate Russian news post into natural English, format per rules.
First line: short headline under 90 chars, no markdown. Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores (e.g., Nature Aging, July 2026).
We need to preserve facts, numbers, names, citations exactly. No added commentary.
We need to identify important facts to bold: numbers like 31 August, 50 thousand fragments, median correlation 0.774, best human strategy 0.763, four series of 30 rounds, etc. Also maybe "Claude Opus 4.7". Also maybe "MPRAbox". Also "CodonBox". Also "Fibonacci positions". Also "Claude raised score". Also "Claude discovered groups of four". Also maybe "14 hidden made-up rules". Also "14 closed sets". Also "31 August authors posted preprint and code". Need to be selective: at most 4-5 double asterisks. Choose the most important numbers: date (31 August), median correlation 0.774, best human 0.763, 50 thousand DNA fragments, four series of 30 rounds. That's 5. Could also include 14 hidden rules, but that would exceed. We'll stick with 5.
We need to ensure we don't bold whole sentences; just wrap the fact.
We need to wrap study/journal citations in single underscores. There's no explicit journal citation in the text; it's a preprint. Maybe we can treat "preprint" as not a journal citation. There's no citation like _Nature Aging... So maybe we don't need any underscores. But we could still include if there is a reference like "authors posted preprint". Not a journal citation. So maybe none.
We must not add source link.
Now produce headline: something like "AI Agents Test Hypotheses in 'Science Sandboxes' with DNA Experiments". Count characters: Let's count: "AI Agents Test Hypotheses in 'Science Sandboxes' with DNA Experiments". That's length? Count: AI(2)+space=3, Agents(6)=9, space=10, Test(4)=14, space=15, Hypotheses(10)=25, space=26, in(2)=28, space=29, 'Science Sandboxes' (including quotes?) Let's count: 'Science Sandboxes' length inside quotes: Science(7) + space=1 + Sandboxes(9)=17, plus two quotes =2? Actually we have single quotes around phrase: 'Science Sandboxes' => 1 quote + 17 + 1 quote =19. So add 19 => 48. space=49, with(4)=53, space=54, DNA(3)=57, space=58, Experiments(10)=68. So 68 chars, under 90. Good.
Now blank line.
Now body paragraphs.
We need to split into short paragraphs 2-3 sentences each.
Let's craft paragraphs:
Paragraph 1: Introduce preprint and concept.
Sentence 1: On 31 August the authors released a preprint and code for “science sandboxes”—test environments where an AI agent forms a hypothesis, selects an experiment, receives a hidden system’s response, and records how that response changes its explanation. Sentence 2: Instead of a single final score, the agent iteratively updates its hypothesis and chooses the next test to discriminate among possible explanations. Sentence 3: The authors assess a narrower skill: can the program, after an observation, explain the result and pick a follow‑up experiment that distinguishes competing hypotheses?
That's 3 sentences.
Paragraph 2: Describe MPRAbox.
Sentence 1: In MPRAbox the agent builds a library of 50 000 DNA fragments for a massively parallel assay that reveals how sequence influences gene activity. Sentence 2: A hidden model scores the fragments; those scores train a predictor that is then evaluated on 14 held‑out sets. Sentence 3: Performance is measured by median correlation, indicating how well predictions match the hidden scores.
Paragraph 3: Results with Claude Opus 4.7.…
🔗 Read original →
First line: short headline under 90 chars, no markdown. Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores (e.g., Nature Aging, July 2026).
We need to preserve facts, numbers, names, citations exactly. No added commentary.
We need to identify important facts to bold: numbers like 31 August, 50 thousand fragments, median correlation 0.774, best human strategy 0.763, four series of 30 rounds, etc. Also maybe "Claude Opus 4.7". Also maybe "MPRAbox". Also "CodonBox". Also "Fibonacci positions". Also "Claude raised score". Also "Claude discovered groups of four". Also maybe "14 hidden made-up rules". Also "14 closed sets". Also "31 August authors posted preprint and code". Need to be selective: at most 4-5 double asterisks. Choose the most important numbers: date (31 August), median correlation 0.774, best human 0.763, 50 thousand DNA fragments, four series of 30 rounds. That's 5. Could also include 14 hidden rules, but that would exceed. We'll stick with 5.
We need to ensure we don't bold whole sentences; just wrap the fact.
We need to wrap study/journal citations in single underscores. There's no explicit journal citation in the text; it's a preprint. Maybe we can treat "preprint" as not a journal citation. There's no citation like _Nature Aging... So maybe we don't need any underscores. But we could still include if there is a reference like "authors posted preprint". Not a journal citation. So maybe none.
We must not add source link.
Now produce headline: something like "AI Agents Test Hypotheses in 'Science Sandboxes' with DNA Experiments". Count characters: Let's count: "AI Agents Test Hypotheses in 'Science Sandboxes' with DNA Experiments". That's length? Count: AI(2)+space=3, Agents(6)=9, space=10, Test(4)=14, space=15, Hypotheses(10)=25, space=26, in(2)=28, space=29, 'Science Sandboxes' (including quotes?) Let's count: 'Science Sandboxes' length inside quotes: Science(7) + space=1 + Sandboxes(9)=17, plus two quotes =2? Actually we have single quotes around phrase: 'Science Sandboxes' => 1 quote + 17 + 1 quote =19. So add 19 => 48. space=49, with(4)=53, space=54, DNA(3)=57, space=58, Experiments(10)=68. So 68 chars, under 90. Good.
Now blank line.
Now body paragraphs.
We need to split into short paragraphs 2-3 sentences each.
Let's craft paragraphs:
Paragraph 1: Introduce preprint and concept.
Sentence 1: On 31 August the authors released a preprint and code for “science sandboxes”—test environments where an AI agent forms a hypothesis, selects an experiment, receives a hidden system’s response, and records how that response changes its explanation. Sentence 2: Instead of a single final score, the agent iteratively updates its hypothesis and chooses the next test to discriminate among possible explanations. Sentence 3: The authors assess a narrower skill: can the program, after an observation, explain the result and pick a follow‑up experiment that distinguishes competing hypotheses?
That's 3 sentences.
Paragraph 2: Describe MPRAbox.
Sentence 1: In MPRAbox the agent builds a library of 50 000 DNA fragments for a massively parallel assay that reveals how sequence influences gene activity. Sentence 2: A hidden model scores the fragments; those scores train a predictor that is then evaluated on 14 held‑out sets. Sentence 3: Performance is measured by median correlation, indicating how well predictions match the hidden scores.
Paragraph 3: Results with Claude Opus 4.7.…
🔗 Read original →
PubMed Central (PMC)
Machine-guided design of cell-type-targeting cis-regulatory elements
Cis-regulatory elements (CREs) control gene expression, orchestrating tissue identity, developmental timing and stimulus responses, which collectively define the thousands of unique cell types in the body1–3. While there is great potential for ...
We need to translate Russian text into English, format as per rules.
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores (e.g. Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly.
Let's extract facts:
- Experience on human cells and mice: turning off ALDH3B2 shifted duct cells to β-like state.
- September 2 (date) in journal Science Translational Medicine article about how turning off one gene changed part of cells lining pancreatic ducts.
- After transplantation of these cells into diabetic mice, glucose level was lower than in animals with control cells.
- β-cells of pancreas secrete insulin — hormone regulating blood sugar level.
- In diabetes these cells are lacking or insufficient, so their function is attempted to be replenished by donor islets and cells grown from stem cells.
- Authors looked for another source: duct cells that pancreas uses to secrete digestive juice.
- To find gene that keeps these cells in original state, researchers performed whole-genome CRISPR screening: they turned off different genes one by one and selected cells where insulin gene activity started.
- For mass search they used PANC-1 duct cell line, which can be grown in large quantity.
- Among eight candidates ALDH3B2 gave in this line the highest insulin gene activity and lowest KRT19 gene, a marker of duct cells.
- Then ALDH3B2 was turned off in purified primary human duct cells.
- In them activity of β-cell genes increased, insulin granules appeared, and raising glucose caused secretion of human insulin.
- In two groups of five diabetic mice each, altered or control cells were transplanted under kidney's outer capsule; in animals with altered cells glucose was lower.
- On day 56 after removal of transplant it returned to control group level, and after glucose injection human insulin was detected in blood.
- Single-cell analysis, where gene activity measured in each cell separately, showed scale of transition: insulin gene worked in 18.1% of cells with ALDH3B2 knocked out and 0.6% of controls.
- About 93% of cells in both groups remained active KRT19 — marker of duct identity.
- Resulted mixed β-like population: part of cells combined duct cell and β-cell markers.
- ALDH3B2 became genetic target for further research on how cells of the organ itself can be directed to replenish lost function.
Now we need to format.
First line: short headline under 90 chars. Something like: "Turning off ALDH3B2 reprograms pancreatic duct cells toward insulin‑producing β‑like state". Count characters: Let's count: "Turning off ALDH3B2 reprograms pancreatic duct cells toward insulin‑producing β‑like state". Count: T(1) ... Let's approximate: It's likely under 90. We'll ensure.
Now blank line.
Then paragraphs: each 2-3 sentences.
We need to wrap key numbers, percentages, gene names, dates in double asterisks. At most 4-5 per post.
Important facts: date September 2, journal Science Translational Medicine, gene ALDH3B2, gene KRT19, PANC-1 line, percentages 18.1% and 0.6%, about 93%, day 56, groups of five mice each.
We need to be selective: maybe choose date, journal, gene ALDH3B2, percentages 18.1% and 0.6%, day 56. That's 5 items.
Wrap each in .…
🔗 Read original →
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores (e.g. Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly.
Let's extract facts:
- Experience on human cells and mice: turning off ALDH3B2 shifted duct cells to β-like state.
- September 2 (date) in journal Science Translational Medicine article about how turning off one gene changed part of cells lining pancreatic ducts.
- After transplantation of these cells into diabetic mice, glucose level was lower than in animals with control cells.
- β-cells of pancreas secrete insulin — hormone regulating blood sugar level.
- In diabetes these cells are lacking or insufficient, so their function is attempted to be replenished by donor islets and cells grown from stem cells.
- Authors looked for another source: duct cells that pancreas uses to secrete digestive juice.
- To find gene that keeps these cells in original state, researchers performed whole-genome CRISPR screening: they turned off different genes one by one and selected cells where insulin gene activity started.
- For mass search they used PANC-1 duct cell line, which can be grown in large quantity.
- Among eight candidates ALDH3B2 gave in this line the highest insulin gene activity and lowest KRT19 gene, a marker of duct cells.
- Then ALDH3B2 was turned off in purified primary human duct cells.
- In them activity of β-cell genes increased, insulin granules appeared, and raising glucose caused secretion of human insulin.
- In two groups of five diabetic mice each, altered or control cells were transplanted under kidney's outer capsule; in animals with altered cells glucose was lower.
- On day 56 after removal of transplant it returned to control group level, and after glucose injection human insulin was detected in blood.
- Single-cell analysis, where gene activity measured in each cell separately, showed scale of transition: insulin gene worked in 18.1% of cells with ALDH3B2 knocked out and 0.6% of controls.
- About 93% of cells in both groups remained active KRT19 — marker of duct identity.
- Resulted mixed β-like population: part of cells combined duct cell and β-cell markers.
- ALDH3B2 became genetic target for further research on how cells of the organ itself can be directed to replenish lost function.
Now we need to format.
First line: short headline under 90 chars. Something like: "Turning off ALDH3B2 reprograms pancreatic duct cells toward insulin‑producing β‑like state". Count characters: Let's count: "Turning off ALDH3B2 reprograms pancreatic duct cells toward insulin‑producing β‑like state". Count: T(1) ... Let's approximate: It's likely under 90. We'll ensure.
Now blank line.
Then paragraphs: each 2-3 sentences.
We need to wrap key numbers, percentages, gene names, dates in double asterisks. At most 4-5 per post.
Important facts: date September 2, journal Science Translational Medicine, gene ALDH3B2, gene KRT19, PANC-1 line, percentages 18.1% and 0.6%, about 93%, day 56, groups of five mice each.
We need to be selective: maybe choose date, journal, gene ALDH3B2, percentages 18.1% and 0.6%, day 56. That's 5 items.
Wrap each in .…
🔗 Read original →
We need to translate Russian news post into natural English, format per rules.
Rules:
1. First line = short headline under 90 chars. No markdown, no '#'.
2. Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
3. Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
4. Wrap study/journal citations and publication references in single underscores _ (e.g., Nature Aging, July 2026).
We must preserve all facts, numbers, names, citations exactly. No commentary.
We need to identify important facts: numbers: 520 genes, 19 programs, 111,003 cells, 20 nearest control cells, 148 people, ages 23 to 91, June analysis (maybe June 2026?), preprint date: 29 August on bioRxiv. Also drug name: venetoclax. Also disease: acute myeloid leukemia. Also method: CRISPRi-Perturb-seq. Also maybe GRP18 program.
We need to wrap key numbers etc in . Must be selective: at most 4-5 per post. So choose maybe: 520 genes, 19 programs, 111,003 cells, 148 people, 29 August (date). Or maybe include venetoclax as drug name. But limit to 4-5. Let's pick: 520 genes, 19 programs, 111,003 cells, 148 people, 29 August. That's 5.
We must not wrap whole sentences. So embed these within sentences but only the numbers/dates inside .
Citations: we have preprint on bioRxiv, maybe also reference to June analysis (maybe a prior study). We need to wrap study/journal citations and publication references in single underscores _. Eg: bioRxiv, 29 August 2026? Actually the preprint date is given: "29 августа на bioRxiv вышел препринт". So we can wrap "bioRxiv, 29 August" maybe. Also mention "июньском разборе" (June analysis) maybe referencing a prior study; we can wrap "June 2026 analysis" but we need to keep exact? The instruction: wrap study/journal citations and publication references in single underscores. So we can put the citation like bioRxiv, 29 August and maybe June 2026 analysis if it's a reference. We'll keep minimal.
We must not add source link.
Now produce headline under 90 chars. Something like: "Scientists map hematopoietic stem cell responses by suppressing 520 genes". Count characters: Let's count: "Scientists map hematopoietic stem cell responses by suppressing 520 genes". That's about 66 characters. Good.
Now body paragraphs, each 2-3 sentences.
We need to include the facts with double asterisks.
Let's craft paragraphs.
Paragraph 1: Introduce preprint, date, method, number of genes, controls, cells.
Paragraph 2: Describe analysis: 19 programs, local response, comparison to controls, etc.
Paragraph 3: Link programs to functional data: transplantation, aging, leukemia, venetoclax.
Paragraph 4: Conclude about utility.
Make sure to wrap numbers in .
We need to ensure not to wrap whole sentences. So embed 520 genes, 19 programs, 111,003 cells, 148 people, 29 August.
Also maybe wrap CRISPRi-Perturb-seq? That's a method name, but maybe not needed as important fact. Could be considered a key name but we already have 5. We'll stick to 5.
Now citations: wrap bioRxiv, 29 August maybe. Also maybe June 2026 analysis for the June analysis.
We need to preserve exact names: "CRISPRi-Perturb-seq". Keep as is.
Now produce final answer.
Check formatting: first line headline, then blank line, then paragraphs separated by blank lines.
Make sure no markdown elsewhere (like no for bold except for the important facts). We'll use double asterisks for those facts.
Let's draft.
Headline:
Scientists map hematopoietic stem cell responses by suppressing 520 genes
Blank line.…
🔗 Read original →
Rules:
1. First line = short headline under 90 chars. No markdown, no '#'.
2. Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
3. Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
4. Wrap study/journal citations and publication references in single underscores _ (e.g., Nature Aging, July 2026).
We must preserve all facts, numbers, names, citations exactly. No commentary.
We need to identify important facts: numbers: 520 genes, 19 programs, 111,003 cells, 20 nearest control cells, 148 people, ages 23 to 91, June analysis (maybe June 2026?), preprint date: 29 August on bioRxiv. Also drug name: venetoclax. Also disease: acute myeloid leukemia. Also method: CRISPRi-Perturb-seq. Also maybe GRP18 program.
We need to wrap key numbers etc in . Must be selective: at most 4-5 per post. So choose maybe: 520 genes, 19 programs, 111,003 cells, 148 people, 29 August (date). Or maybe include venetoclax as drug name. But limit to 4-5. Let's pick: 520 genes, 19 programs, 111,003 cells, 148 people, 29 August. That's 5.
We must not wrap whole sentences. So embed these within sentences but only the numbers/dates inside .
Citations: we have preprint on bioRxiv, maybe also reference to June analysis (maybe a prior study). We need to wrap study/journal citations and publication references in single underscores _. Eg: bioRxiv, 29 August 2026? Actually the preprint date is given: "29 августа на bioRxiv вышел препринт". So we can wrap "bioRxiv, 29 August" maybe. Also mention "июньском разборе" (June analysis) maybe referencing a prior study; we can wrap "June 2026 analysis" but we need to keep exact? The instruction: wrap study/journal citations and publication references in single underscores. So we can put the citation like bioRxiv, 29 August and maybe June 2026 analysis if it's a reference. We'll keep minimal.
We must not add source link.
Now produce headline under 90 chars. Something like: "Scientists map hematopoietic stem cell responses by suppressing 520 genes". Count characters: Let's count: "Scientists map hematopoietic stem cell responses by suppressing 520 genes". That's about 66 characters. Good.
Now body paragraphs, each 2-3 sentences.
We need to include the facts with double asterisks.
Let's craft paragraphs.
Paragraph 1: Introduce preprint, date, method, number of genes, controls, cells.
Paragraph 2: Describe analysis: 19 programs, local response, comparison to controls, etc.
Paragraph 3: Link programs to functional data: transplantation, aging, leukemia, venetoclax.
Paragraph 4: Conclude about utility.
Make sure to wrap numbers in .
We need to ensure not to wrap whole sentences. So embed 520 genes, 19 programs, 111,003 cells, 148 people, 29 August.
Also maybe wrap CRISPRi-Perturb-seq? That's a method name, but maybe not needed as important fact. Could be considered a key name but we already have 5. We'll stick to 5.
Now citations: wrap bioRxiv, 29 August maybe. Also maybe June 2026 analysis for the June analysis.
We need to preserve exact names: "CRISPRi-Perturb-seq". Keep as is.
Now produce final answer.
Check formatting: first line headline, then blank line, then paragraphs separated by blank lines.
Make sure no markdown elsewhere (like no for bold except for the important facts). We'll use double asterisks for those facts.
Let's draft.
Headline:
Scientists map hematopoietic stem cell responses by suppressing 520 genes
Blank line.…
🔗 Read original →
Model predicts timing windows for partial cellular reprogramming via OSK(M)
On 1 September Matteo Chiarki and Steffen Rudolph posted a theoretical preprint on bioRxiv. In a minimal model and computer simulations, transient activation of OSK(M) — proteins that alter gene activity — produces three distinct outcomes. Epigenetic marks that regulate genes remodel faster than the three‑dimensional packing of DNA in the model.
Partial reprogramming should change age‑related gene‑expression signatures while preserving cell identity. The authors linked epigenetic marks to chromatin — DNA with proteins in the nucleus — noting that marks influence chromatin packing and that contacts between distant DNA regions help maintain a similar mark distribution. A short pulse nearly restores the original state; an intermediate duration makes the average mark balance sensitive to small perturbations at the boundary between stable states, while chromatin stays compact and retains long‑range contacts. After OSK(M) is switched off, this network restores mark correlations. A long pulse opens chromatin, reduces long‑range contacts, and erases correlational memory.
The authors tested one model prediction using published mouse‑cell data. In embryonic fibroblasts, correlations of the repressive epigenetic mark H3K9me3 decayed more slowly in dense B‑compartments than in open A‑compartments; in embryonic stem cells with weaker chromatin compartmentalization the difference was smaller, qualitatively supporting the model’s link between chromatin compactness and correlation range. In their 2025 preprint Chiarki, Benjamin Simons and Rudolph described three timescales of methylation changes — fast molecular events, intermediate dynamics, and slow transitions — and the new work adds the three‑dimensional shape of chromatin to this framework.
They propose measuring chromatin contacts and several epigenetic marks over time during OSK(M) induction. In the model, altering chromatin compactness or the feedback between mark reading and writing should shift the boundaries between the three regimes.
🔗 Read original →
On 1 September Matteo Chiarki and Steffen Rudolph posted a theoretical preprint on bioRxiv. In a minimal model and computer simulations, transient activation of OSK(M) — proteins that alter gene activity — produces three distinct outcomes. Epigenetic marks that regulate genes remodel faster than the three‑dimensional packing of DNA in the model.
Partial reprogramming should change age‑related gene‑expression signatures while preserving cell identity. The authors linked epigenetic marks to chromatin — DNA with proteins in the nucleus — noting that marks influence chromatin packing and that contacts between distant DNA regions help maintain a similar mark distribution. A short pulse nearly restores the original state; an intermediate duration makes the average mark balance sensitive to small perturbations at the boundary between stable states, while chromatin stays compact and retains long‑range contacts. After OSK(M) is switched off, this network restores mark correlations. A long pulse opens chromatin, reduces long‑range contacts, and erases correlational memory.
The authors tested one model prediction using published mouse‑cell data. In embryonic fibroblasts, correlations of the repressive epigenetic mark H3K9me3 decayed more slowly in dense B‑compartments than in open A‑compartments; in embryonic stem cells with weaker chromatin compartmentalization the difference was smaller, qualitatively supporting the model’s link between chromatin compactness and correlation range. In their 2025 preprint Chiarki, Benjamin Simons and Rudolph described three timescales of methylation changes — fast molecular events, intermediate dynamics, and slow transitions — and the new work adds the three‑dimensional shape of chromatin to this framework.
They propose measuring chromatin contacts and several epigenetic marks over time during OSK(M) induction. In the model, altering chromatin compactness or the feedback between mark reading and writing should shift the boundaries between the three regimes.
🔗 Read original →
We need to translate Russian news post into natural English, format per rules.
First line: short headline under 90 chars, no markdown. Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. At most 4-5 per post. Wrap study/journal citations and publication references in single underscores.
We need to preserve facts, numbers, names, citations exactly. No added commentary.
We need to identify important facts: Generation Lab, Michael West, Matt Kaberlain, Alina Su, 1 Generation (injection combination), date: September 1 (Michael West post), September 2 (Alina Su response). Also mention eight people data, one participant anecdote, one blood marker. Also mention pilot study data. Also mention that Generation Lab began assigning 1 Generation to limited group before dispute. Also mention controlled trial design: random allocation, double-blind, placebo.
We need to wrap key numbers/dates/names in . For example: Generation Lab, Michael West, Matt Kaberlain, Alina Su, 1 Generation, September 1, September 2, eight people, maybe one blood marker. But limit to 4-5 total. So choose most important: dates, drug name, company name, maybe number of participants.
We need to wrap study/journal citations in single underscores. There are none explicit citations like journal names. There's mention of "pilot study". No journal citation. So maybe none.
We must not add source link.
We need to produce only formatted translation.
Let's craft headline: "Experts Call for Controlled Trial to Test Generation Lab's Anti‑Aging Claims". Count characters: let's count: "Experts Call for Controlled Trial to Test Generation Lab's Anti‑Aging Claims". Count: Experts(7) + space=1 =>8, Call(4)=12, space=13, for(3)=16, space=17, Controlled(10)=27, space=28, Trial(5)=33, space=34, to(2)=36, space=37, Test(4)=41, space=42, Generation(10)=52, space=53, Lab's(4 inc apostrophe?) Actually "Lab's" =5 inc apostrophe? L a b ' s =5, so 58, space=59, Anti‑Aging (maybe hyphen) let's count: Anti‑Aging = 10? A n t i ‑ A g i n g =10 inc hyphen? We'll approximate 10 =>69, space=70, Claims(6)=76. Under 90. Good.
Now blank line.
Now body paragraphs.
Paragraph 1: Introduce Michael West's call for controlled trial on September 1, referencing his review of a fragment of Generation Lab's presentation about 1 Generation injection combination, data from eight people, one participant anecdote, one blood marker, linking therapy to regeneration and tissue improvement. Wrap important facts: Michael West, September 1, Generation Lab, 1 Generation, eight people. That's 5 items, okay.
Paragraph 2: Matt Kaberlain's support for precise language, noting scientific basis real, consisting of two FDA‑approved drugs and animal data, distinguishing basis from needed placebo comparison. Wrap: Matt Kaberlain, FDA‑approved, maybe two FDA‑approved drugs but that's phrase. We need limit to 4-5 total across whole post; we already used 5 in paragraph1. Can't exceed total 4-5 per post. So we need to be selective overall, max 4-5 total. So we need to reduce.
We need at most 4-5 double asterisk wrapped facts total. So we need to choose maybe 4 facts: Generation Lab, 1 Generation, September 1, September 2? Or include Michael West and Matt Kaberlain as names. Let's decide: we need to include key numbers, percentages, drug/company/gene names, dates. So we need company name, drug name, dates, maybe number of participants (eight). That's four: Generation Lab, 1 Generation, September 1, eight people. Could also include September 2 but that would be fifth. We'll keep four.…
🔗 Read original →
First line: short headline under 90 chars, no markdown. Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks. At most 4-5 per post. Wrap study/journal citations and publication references in single underscores.
We need to preserve facts, numbers, names, citations exactly. No added commentary.
We need to identify important facts: Generation Lab, Michael West, Matt Kaberlain, Alina Su, 1 Generation (injection combination), date: September 1 (Michael West post), September 2 (Alina Su response). Also mention eight people data, one participant anecdote, one blood marker. Also mention pilot study data. Also mention that Generation Lab began assigning 1 Generation to limited group before dispute. Also mention controlled trial design: random allocation, double-blind, placebo.
We need to wrap key numbers/dates/names in . For example: Generation Lab, Michael West, Matt Kaberlain, Alina Su, 1 Generation, September 1, September 2, eight people, maybe one blood marker. But limit to 4-5 total. So choose most important: dates, drug name, company name, maybe number of participants.
We need to wrap study/journal citations in single underscores. There are none explicit citations like journal names. There's mention of "pilot study". No journal citation. So maybe none.
We must not add source link.
We need to produce only formatted translation.
Let's craft headline: "Experts Call for Controlled Trial to Test Generation Lab's Anti‑Aging Claims". Count characters: let's count: "Experts Call for Controlled Trial to Test Generation Lab's Anti‑Aging Claims". Count: Experts(7) + space=1 =>8, Call(4)=12, space=13, for(3)=16, space=17, Controlled(10)=27, space=28, Trial(5)=33, space=34, to(2)=36, space=37, Test(4)=41, space=42, Generation(10)=52, space=53, Lab's(4 inc apostrophe?) Actually "Lab's" =5 inc apostrophe? L a b ' s =5, so 58, space=59, Anti‑Aging (maybe hyphen) let's count: Anti‑Aging = 10? A n t i ‑ A g i n g =10 inc hyphen? We'll approximate 10 =>69, space=70, Claims(6)=76. Under 90. Good.
Now blank line.
Now body paragraphs.
Paragraph 1: Introduce Michael West's call for controlled trial on September 1, referencing his review of a fragment of Generation Lab's presentation about 1 Generation injection combination, data from eight people, one participant anecdote, one blood marker, linking therapy to regeneration and tissue improvement. Wrap important facts: Michael West, September 1, Generation Lab, 1 Generation, eight people. That's 5 items, okay.
Paragraph 2: Matt Kaberlain's support for precise language, noting scientific basis real, consisting of two FDA‑approved drugs and animal data, distinguishing basis from needed placebo comparison. Wrap: Matt Kaberlain, FDA‑approved, maybe two FDA‑approved drugs but that's phrase. We need limit to 4-5 total across whole post; we already used 5 in paragraph1. Can't exceed total 4-5 per post. So we need to be selective overall, max 4-5 total. So we need to reduce.
We need at most 4-5 double asterisk wrapped facts total. So we need to choose maybe 4 facts: Generation Lab, 1 Generation, September 1, September 2? Or include Michael West and Matt Kaberlain as names. Let's decide: we need to include key numbers, percentages, drug/company/gene names, dates. So we need company name, drug name, dates, maybe number of participants (eight). That's four: Generation Lab, 1 Generation, September 1, eight people. Could also include September 2 but that would be fifth. We'll keep four.…
🔗 Read original →
Nature
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
Nature - Tissues of the body regenerate well in young individuals, less so in older individuals. To find out if this decline is irreversible, or subject to factors in the circulation, Conboy et al....
We need to translate Russian news post into natural English, format per rules.
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores _ (e.g., Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly.
Let's extract facts:
- Essay by Jen Pollock Michel about aging links youth cult with fear of becoming a burden.
- September 1 writer Jen Pollock Michel published in Christianity Today a review of Jen Wilkin's book "Dust to Dust" about aging and family care.
- She traces how desire to look young connects with fear of becoming invisible and needing help.
- Michel begins with a photograph of 60-year-old Elizabeth Elliot, taken in 1986.
- On the portrait visible gray hair, wrinkles around eyes and folds on neck.
- Michel sees these signs of age as what the cosmetic industry has trained us to hide.
- Behind anxiety about appearance, she writes, lies fear of losing attractiveness, becoming invisible to others and burdening loved ones.
- Wilkin describes human life as a cycle of receiving and giving care: child receives it, adult cares for younger and older, elderly person again receives help.
- Such mutual aid links generations and preserves human dignity.
- Wilkin formulates it thus: "I want to direct the unearned gift of good health and long years to serving others. I want to relate to my body with reverence, but not make it the highest goal."
- To explain this anxiety, Michel recounts Rebecca Konyndyk DeYoung's book on vanity.
- DeYoung calls vanity dependence on public approval: fearing its loss, a person tries to hide what they consider their flaw.
- In the review, fear of aging is linked to fear that others will stop noticing the person, consider them needed and independent.
- Michel includes in this conversation longevity medicine: in her view, fear of future helplessness may push a person to try to avoid dependence.
- In a June conversation with Ross Douthat, Christian Angermayer also separated health from appearance: excess weight he linked to health risk, hair loss he suggested to leave alone, and desire to live longer — with time spent with children.
- In the review sit two motifs: preserve strength and be near loved ones; hold onto youth, beauty, independence and others' approval.
We need to include numbers: 60-year-old, 1986, September 1, June conversation (no year given). Possibly also "Christianity Today" date? Not given.
We need to wrap key numbers, percentages, drug/company/gene names, dates in . At most 4-5 per post.
Potential important facts: "60-year-old", "1986", "September 1", "June". That's four.
We could also include "Christianity Today" but that's a publication name, not a number/date. Could be considered a citation? It's a publication reference; we should wrap in single underscores Christianity Today? The rule: wrap study/journal citations and publication references in single underscores. So we should wrap "Christianity Today" in Christianity Today.
Also "Dust to Dust" is a book title; maybe treat as publication reference? It's a book; could be considered a citation; we can wrap in Dust to Dust.
Also "Rebecca Konyndyk DeYoung" is author; not needed.
We need to keep at most 4-5 double asterisks. Let's pick: 60-year-old, 1986, September 1, June. That's four.
Now we need to ensure we don't wrap whole sentences. Just those numbers.…
🔗 Read original →
First line: short headline under 90 chars, no markdown, no '#'.
Then blank line, then body split into short paragraphs (2-3 sentences each), separated by blank lines.
Wrap few genuinely important facts — key numbers, percentages, drug/company/gene names, dates — in double asterisks . At most 4-5 per post, never a whole sentence.
Wrap study/journal citations and publication references in single underscores _ (e.g., Nature Aging, July 2026).
We need to preserve all facts, numbers, names, citations exactly.
Let's extract facts:
- Essay by Jen Pollock Michel about aging links youth cult with fear of becoming a burden.
- September 1 writer Jen Pollock Michel published in Christianity Today a review of Jen Wilkin's book "Dust to Dust" about aging and family care.
- She traces how desire to look young connects with fear of becoming invisible and needing help.
- Michel begins with a photograph of 60-year-old Elizabeth Elliot, taken in 1986.
- On the portrait visible gray hair, wrinkles around eyes and folds on neck.
- Michel sees these signs of age as what the cosmetic industry has trained us to hide.
- Behind anxiety about appearance, she writes, lies fear of losing attractiveness, becoming invisible to others and burdening loved ones.
- Wilkin describes human life as a cycle of receiving and giving care: child receives it, adult cares for younger and older, elderly person again receives help.
- Such mutual aid links generations and preserves human dignity.
- Wilkin formulates it thus: "I want to direct the unearned gift of good health and long years to serving others. I want to relate to my body with reverence, but not make it the highest goal."
- To explain this anxiety, Michel recounts Rebecca Konyndyk DeYoung's book on vanity.
- DeYoung calls vanity dependence on public approval: fearing its loss, a person tries to hide what they consider their flaw.
- In the review, fear of aging is linked to fear that others will stop noticing the person, consider them needed and independent.
- Michel includes in this conversation longevity medicine: in her view, fear of future helplessness may push a person to try to avoid dependence.
- In a June conversation with Ross Douthat, Christian Angermayer also separated health from appearance: excess weight he linked to health risk, hair loss he suggested to leave alone, and desire to live longer — with time spent with children.
- In the review sit two motifs: preserve strength and be near loved ones; hold onto youth, beauty, independence and others' approval.
We need to include numbers: 60-year-old, 1986, September 1, June conversation (no year given). Possibly also "Christianity Today" date? Not given.
We need to wrap key numbers, percentages, drug/company/gene names, dates in . At most 4-5 per post.
Potential important facts: "60-year-old", "1986", "September 1", "June". That's four.
We could also include "Christianity Today" but that's a publication name, not a number/date. Could be considered a citation? It's a publication reference; we should wrap in single underscores Christianity Today? The rule: wrap study/journal citations and publication references in single underscores. So we should wrap "Christianity Today" in Christianity Today.
Also "Dust to Dust" is a book title; maybe treat as publication reference? It's a book; could be considered a citation; we can wrap in Dust to Dust.
Also "Rebecca Konyndyk DeYoung" is author; not needed.
We need to keep at most 4-5 double asterisks. Let's pick: 60-year-old, 1986, September 1, June. That's four.
Now we need to ensure we don't wrap whole sentences. Just those numbers.…
🔗 Read original →
Christianity Today
Old Age Is Not a Problem to Be Solved - Christianity Today
In a society that treasures youth and equates beauty with worth, three books offer a better perspective on aging.